Načítá se...
The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension
1 In a double-blind, placebo controlled, crossover study 12 patients with essential hypertension received single doses of 5, 10 and 20 mg of cilazapril. 2 Peak plasma levels of cilazaprilat and the 24 h areas under curve were directly proportional to dose. 3 The elimination half-life during the firs...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
1989
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1379756/ https://ncbi.nlm.nih.gov/pubmed/2548553 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|